4
Changes in Ownership
LENZ Therapeutics, Inc. Filed Acc 0001209191-22-004735
10% owner bought 123,000 shares at an average $8.94 ($1,099,100)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Samsara BioCapital, L.P. 10% owner | 2022-01-21 | Purchase | +100,000 | $8.99 | $899,000 | 8,011,850 | I |
| Samsara BioCapital, L.P. 10% owner | 2022-01-24 | Purchase | +23,000 | $8.70 | $200,100 | 8,034,850 | I |
| Open-market purchases · 123,000 sh · avg $8.94 · $1,099,100 | |||||||
Loading xslF345X03/doc4.xml…